1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow ERYtech Pharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone for the Treatment of TNBC (TRYbeCA-2) eryaspase (L-asparaginase encapsulated in red blood cells), Gemcitabine, Carboplatin - Triple Negative Breast Cancer | Phase 2 / Phase 3 | Terminated | ERYtech Pharma | 27 | 2019-06-13 | 2022-08-01 |
Triple Negative Breast Neoplasms (1)
Carboplatin (1) · Erythrocyte Count (1) · Gemcitabine (1) · eryaspase (1)
Belgium (1) · Hungary (1) · Spain (1)